The Kenya Medical Supplies Authority (Kemsa) has been put on the spot for failure to disclose that it was holding expired drug stocks worth Sh328 million in the year ending June 2021.
Auditor-General Nancy Gathungu says the agency’s annual reports and financial statements did not indicate it had Sh191.9 million worth of expired stock financed by Kemsa Capital Fund and Sh136.4 million worth of drugs bought by third parties.
